• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Macleods Pharmaceutical`s Generics Hydralazine Hydrochloride Receives Approval in US

    FDA

    Enforcement Report - Week of February 21, 2024

    FDA

    Enforcement Report - Week of February 14, 2024

    FDA

    I3 Pharms` Generic Isosorbide Dinitrate & Hydralazine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of October 11, 2023

    FDA

    Upsher-Smith`s Generic Hydralazine HCL Receives Receives Approval in the U.S.

    FDA

    RiconPharma`s Generic Hydralazine HCL;Isosorbide Receives Approval in US

    FDA

    Enforcement Report - Week of March 23, 2022

    FDA

    FDA Drug Shortages: Hydralazine Hydrochloride Injection

    ACCESSDATA

    Hikma launches Hydralazine Hydrochloride Injection, USP

    DRUGSTORENEWS

    Hikma`s Generic Hydralazine Hydrochloride Receives Approval In US

    FDA

    Appco Pharma LLC’s Generic Hydralazine Hydrochloride Receives Approval in the US

    FDA

    Enforcement Report - Week of April 19, 2017

    FDA

    Mylan Launches Generic Apresoline® Injection

    PR NEWSWIRE

    Mylan Institutional`s Generic Hydralazine Hydrochloride approved in US for High Blood Pressure

    FDA

    X-Gen`s Generic Hydralazine Hcl (20Mg/Ml) Approved in US For Hypertension

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.